+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Global Skin Allergy Therapeutics Market by Indication (Angioedema, Contact Dermatitis, Eczema), Route of Administration (Oral, Parenteral), Treatment, Distribution Channel - Forecast 2024-2030

  • PDF Icon

    Report

  • 183 Pages
  • March 2024
  • Region: Global
  • 360iResearch™
  • ID: 5889278
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Skin Allergy Therapeutics Market size was estimated at USD 5.04 billion in 2023, USD 5.43 billion in 2024, and is expected to grow at a CAGR of 8.15% to reach USD 8.73 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Skin Allergy Therapeutics Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Skin Allergy Therapeutics Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Skin Allergy Therapeutics Market, highlighting leading vendors and their innovative profiles. These include ALK-Abelló A/S, Astellas Pharma International B.V., AstraZeneca PLC, Bausch Health Companies Inc, Bayer AG, DBV Technologies Inc., Dr.Reddy's Laboratories Limited, Eisai Co., Ltd., Eli Lilly and Company, GlaxoSmithKline PLC, Glenmark Pharmaceuticals Ltd., Hefei Home Sunshine Pharmaceutical Technology Co., Ltd., HYCOR Biomedical, LLC, Johnson & Johnson Consumer Inc., LEO Pharma A/S, Ligand Pharmaceuticals Incorporated, Lincoln Diagnostics, Inc., Merck KGaA, Omega Diagnostics Group PLC, Pfizer Inc., Piramal Enterprises Limited, Sanofi S.A., Sun Pharmaceutical Industries Ltd., Synnat Pharma Private Limited, Teva Pharmaceutical Industries Ltd., and Viatris Inc.

Market Segmentation & Coverage

This research report categorizes the Skin Allergy Therapeutics Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Indication
    • Angioedema
    • Contact Dermatitis
    • Eczema
    • Urticaria
  • Route of Administration
    • Oral
    • Parenteral
  • Treatment
    • Immunotherapy
    • Oral Medications
    • Phototherapy
    • Topical Treatments
  • Distribution Channel
    • Offline
      • Drug Stores
      • Retail Pharmacies
    • Online
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

  1. What is the market size and forecast of the Skin Allergy Therapeutics Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Skin Allergy Therapeutics Market?
  3. What are the technology trends and regulatory frameworks in the Skin Allergy Therapeutics Market?
  4. What is the market share of the leading vendors in the Skin Allergy Therapeutics Market?
  5. Which modes and strategic moves are suitable for entering the Skin Allergy Therapeutics Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Skin Allergy Therapeutics Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising prevalence of skin allergy conditions among population
5.1.1.2. Growing awareness of skincare and detection of skin allergies
5.1.2. Restraints
5.1.2.1. High costs associated with skincare treatments
5.1.3. Opportunities
5.1.3.1. Robust research activities to develop novel skin allergy therapeutics
5.1.3.2. Improved healthcare infrastructure and medical spendings
5.1.4. Challenges
5.1.4.1. Stringent regulatory requirements for therapeutics development
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Skin Allergy Therapeutics Market, by Indication
6.1. Introduction
6.2. Angioedema
6.3. Contact Dermatitis
6.4. Eczema
6.5. Urticaria
7. Skin Allergy Therapeutics Market, by Route of Administration
7.1. Introduction
7.2. Oral
7.3. Parenteral
8. Skin Allergy Therapeutics Market, by Treatment
8.1. Introduction
8.2. Immunotherapy
8.3. Oral Medications
8.4. Phototherapy
8.5. Topical Treatments
9. Skin Allergy Therapeutics Market, by Distribution Channel
9.1. Introduction
9.2. Offline
9.3.1. Drug Stores
9.3.2. Retail Pharmacies
9.3. Online
10. Americas Skin Allergy Therapeutics Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Skin Allergy Therapeutics Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Skin Allergy Therapeutics Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.2. Market Share Analysis, By Key Player
13.3. Competitive Scenario Analysis, By Key Player
14. Competitive Portfolio
14.1. Key Company Profiles
14.1.1. ALK-Abelló A/S
14.1.2. Astellas Pharma International B.V.
14.1.3. AstraZeneca PLC
14.1.4. Bausch Health Companies Inc
14.1.5. Bayer AG
14.1.6. DBV Technologies Inc.
14.1.7. Dr.Reddy's Laboratories Limited
14.1.8. Eisai Co., Ltd.
14.1.9. Eli Lilly and Company
14.1.10. GlaxoSmithKline PLC
14.1.11. Glenmark Pharmaceuticals Ltd.
14.1.12. Hefei Home Sunshine Pharmaceutical Technology Co., Ltd.
14.1.13. HYCOR Biomedical, LLC
14.1.14. Johnson & Johnson Consumer Inc.
14.1.15. LEO Pharma A/S
14.1.16. Ligand Pharmaceuticals Incorporated
14.1.17. Lincoln Diagnostics, Inc.
14.1.18. Merck KGaA
14.1.19. Omega Diagnostics Group PLC
14.1.20. Pfizer Inc.
14.1.21. Piramal Enterprises Limited
14.1.22. Sanofi S.A.
14.1.23. Sun Pharmaceutical Industries Ltd.
14.1.24. Synnat Pharma Private Limited
14.1.25. Teva Pharmaceutical Industries Ltd.
14.1.26. Viatris Inc.
14.2. Key Product Portfolio
15. Appendix
15.1. Discussion Guide
15.2. License & Pricing
List of Figures
FIGURE 1. SKIN ALLERGY THERAPEUTICS MARKET RESEARCH PROCESS
FIGURE 2. SKIN ALLERGY THERAPEUTICS MARKET SIZE, 2023 VS 2030
FIGURE 3. SKIN ALLERGY THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. SKIN ALLERGY THERAPEUTICS MARKET DYNAMICS
FIGURE 7. SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
FIGURE 8. SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
FIGURE 10. SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY TREATMENT, 2023 VS 2030 (%)
FIGURE 12. SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY TREATMENT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
FIGURE 14. SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. AMERICAS SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 18. UNITED STATES SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. SKIN ALLERGY THERAPEUTICS MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 24. SKIN ALLERGY THERAPEUTICS MARKET SHARE, BY KEY PLAYER, 2023
List of Tables
TABLE 1. SKIN ALLERGY THERAPEUTICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. SKIN ALLERGY THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 6. SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY ANGIOEDEMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY CONTACT DERMATITIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY ECZEMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY URTICARIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 11. SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY PARENTERAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 14. SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY IMMUNOTHERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY ORAL MEDICATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY PHOTOTHERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY TOPICAL TREATMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 19. SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY OFFLINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 21. SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY DRUG STORES, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY ONLINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. AMERICAS SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 25. AMERICAS SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 26. AMERICAS SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 27. AMERICAS SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 28. AMERICAS SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 29. AMERICAS SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 30. ARGENTINA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 31. ARGENTINA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 32. ARGENTINA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 33. ARGENTINA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 34. ARGENTINA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 35. BRAZIL SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 36. BRAZIL SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 37. BRAZIL SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 38. BRAZIL SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 39. BRAZIL SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 40. CANADA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 41. CANADA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 42. CANADA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 43. CANADA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 44. CANADA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 45. MEXICO SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 46. MEXICO SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 47. MEXICO SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 48. MEXICO SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 49. MEXICO SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 50. UNITED STATES SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 51. UNITED STATES SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 52. UNITED STATES SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 53. UNITED STATES SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 54. UNITED STATES SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 55. UNITED STATES SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 56. ASIA-PACIFIC SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 57. ASIA-PACIFIC SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 58. ASIA-PACIFIC SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 59. ASIA-PACIFIC SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 60. ASIA-PACIFIC SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 61. ASIA-PACIFIC SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 62. AUSTRALIA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 63. AUSTRALIA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 64. AUSTRALIA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 65. AUSTRALIA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 66. AUSTRALIA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 67. CHINA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 68. CHINA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 69. CHINA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 70. CHINA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 71. CHINA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 72. INDIA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 73. INDIA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 74. INDIA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 75. INDIA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 76. INDIA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 77. INDONESIA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 78. INDONESIA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 79. INDONESIA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 80. INDONESIA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 81. INDONESIA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 82. JAPAN SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 83. JAPAN SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 84. JAPAN SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 85. JAPAN SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 86. JAPAN SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 87. MALAYSIA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 88. MALAYSIA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 89. MALAYSIA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 90. MALAYSIA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 91. MALAYSIA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 92. PHILIPPINES SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 93. PHILIPPINES SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 94. PHILIPPINES SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 95. PHILIPPINES SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 96. PHILIPPINES SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 97. SINGAPORE SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 98. SINGAPORE SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 99. SINGAPORE SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 100. SINGAPORE SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 101. SINGAPORE SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 102. SOUTH KOREA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 103. SOUTH KOREA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 104. SOUTH KOREA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 105. SOUTH KOREA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 106. SOUTH KOREA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 107. TAIWAN SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 108. TAIWAN SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 109. TAIWAN SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 110. TAIWAN SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 111. TAIWAN SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 112. THAILAND SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 113. THAILAND SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 114. THAILAND SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 115. THAILAND SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 116. THAILAND SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 117. VIETNAM SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 118. VIETNAM SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 119. VIETNAM SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 120. VIETNAM SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 121. VIETNAM SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 122. EUROPE, MIDDLE EAST & AFRICA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 123. EUROPE, MIDDLE EAST & AFRICA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 124. EUROPE, MIDDLE EAST & AFRICA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 125. EUROPE, MIDDLE EAST & AFRICA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 126. EUROPE, MIDDLE EAST & AFRICA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 127. EUROPE, MIDDLE EAST & AFRICA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 128. DENMARK SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 129. DENMARK SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 130. DENMARK SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 131. DENMARK SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 132. DENMARK SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 133. EGYPT SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 134. EGYPT SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 135. EGYPT SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 136. EGYPT SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 137. EGYPT SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 138. FINLAND SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 139. FINLAND SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 140. FINLAND SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 141. FINLAND SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 142. FINLAND SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 143. FRANCE SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 144. FRANCE SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 145. FRANCE SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 146. FRANCE SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 147. FRANCE SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 148. GERMANY SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 149. GERMANY SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 150. GERMANY SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 151. GERMANY SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 152. GERMANY SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 153. ISRAEL SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 154. ISRAEL SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 155. ISRAEL SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 156. ISRAEL SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 157. ISRAEL SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 158. ITALY SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 159. ITALY SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 160. ITALY SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 161. ITALY SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 162. ITALY SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 163. NETHERLANDS SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 164. NETHERLANDS SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 165. NETHERLANDS SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 166. NETHERLANDS SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 167. NETHERLANDS SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 168. NIGERIA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 169. NIGERIA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 170. NIGERIA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 171. NIGERIA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 172. NIGERIA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 173. NORWAY SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 174. NORWAY SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 175. NORWAY SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 176. NORWAY SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 177. NORWAY SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 178. POLAND SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 179. POLAND SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 180. POLAND SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 181. POLAND SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 182. POLAND SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 183. QATAR SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 184. QATAR SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 185. QATAR SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 186. QATAR SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 187. QATAR SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 188. RUSSIA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 189. RUSSIA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 190. RUSSIA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 191. RUSSIA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 192. RUSSIA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 193. SAUDI ARABIA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 194. SAUDI ARABIA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 195. SAUDI ARABIA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 196. SAUDI ARABIA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 197. SAUDI ARABIA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 198. SOUTH AFRICA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 199. SOUTH AFRICA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 200. SOUTH AFRICA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 201. SOUTH AFRICA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 202. SOUTH AFRICA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 203. SPAIN SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 204. SPAIN SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 205. SPAIN SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 206. SPAIN SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 207. SPAIN SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 208. SWEDEN SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 209. SWEDEN SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 210. SWEDEN SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 211. SWEDEN SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 212. SWEDEN SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 213. SWITZERLAND SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 214. SWITZERLAND SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 215. SWITZERLAND SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 216. SWITZERLAND SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 217. SWITZERLAND SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 218. TURKEY SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 219. TURKEY SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 220. TURKEY SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 221. TURKEY SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 222. TURKEY SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 223. UNITED ARAB EMIRATES SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 224. UNITED ARAB EMIRATES SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 225. UNITED ARAB EMIRATES SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 226. UNITED ARAB EMIRATES SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 227. UNITED ARAB EMIRATES SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 228. UNITED KINGDOM SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 229. UNITED KINGDOM SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 230. UNITED KINGDOM SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 231. UNITED KINGDOM SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 232. UNITED KINGDOM SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 233. SKIN ALLERGY THERAPEUTICS MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 234. SKIN ALLERGY THERAPEUTICS MARKET SHARE, BY KEY PLAYER, 2023
TABLE 235. SKIN ALLERGY THERAPEUTICS MARKET LICENSE & PRICING

Companies Mentioned

  • ALK-Abelló A/S
  • Astellas Pharma International B.V.
  • AstraZeneca PLC
  • Bausch Health Companies Inc
  • Bayer AG
  • DBV Technologies Inc.
  • Dr.Reddy's Laboratories Limited
  • Eisai Co., Ltd.
  • Eli Lilly and Company
  • GlaxoSmithKline PLC
  • Glenmark Pharmaceuticals Ltd.
  • Hefei Home Sunshine Pharmaceutical Technology Co., Ltd.
  • HYCOR Biomedical, LLC
  • Johnson & Johnson Consumer Inc.
  • LEO Pharma A/S
  • Ligand Pharmaceuticals Incorporated
  • Lincoln Diagnostics, Inc.
  • Merck KGaA
  • Omega Diagnostics Group PLC
  • Pfizer Inc.
  • Piramal Enterprises Limited
  • Sanofi S.A.
  • Sun Pharmaceutical Industries Ltd.
  • Synnat Pharma Private Limited
  • Teva Pharmaceutical Industries Ltd.
  • Viatris Inc.

Methodology

Loading
LOADING...

Table Information